Table 3:

Clinical characteristics of patients who presented with type III lesionsa

PatientSex/Age (yr)SymptomsLesion LocationLesion Size (cm)Durationb (mo) to Classic GBIDH1 Mutation
1F/95Facial palsyRight frontal3 × 1.53NS
2M/48Generalized seizureRight frontal4 × 2NA
3M/69Focal seizureRight parietal2.5 × 1.23
4F/59Slurred speechLeft insular3 × 1.3NANS
5F/55Hand numbnessRight parietal2.1 × 1.3NA
6F/69Leg weaknessRight frontal3 × 1.2NANS
7F/35Leg numbnessLeft frontal2.5 × 1.31
8M/65Generalized seizureLeft parietal2.6 × 2.6NANS
9M/45Generalized seizureLeft temporal3 × 31NS
10M/58Generalized seizureLeft frontal1.5 × 1NANS
11M/43Generalized seizureLeft frontal3 × 1.8NANS
12M/62Generalized seizureLeft temporal2.4 × 2.36
  • Note:—NA indicates not available; NS, not studied; −, negative.

  • a The lesions refer to FLAIR/T2-weighted hyperintensities involving the cortex and subcortical WM, with focal contrast enhancement at the GM-WM junction. The size of contrast-enhancing foci is not shown because they are about ≤1 cm.

  • b The duration is the time interval between the first and follow-up MR imaging studies showing classic GB. NA indicates that type III lesions were resected before progressing to classic GB.